Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma
Titel:
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma
Auteur:
Horowitz, Neil S. Penson, Richard T. Duda, Dan G. di Tomaso, Emmanuelle Boucher, Yves Ancukiewicz, Marek Cohen, Kenneth S. Berlin, Suzanne Krasner, Carolyn N. Moses, Marsha A. Jain, Rakesh K.